Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)

South Korea flag South Korea · Delayed Price · Currency is KRW
30,050
-400 (-1.31%)
At close: Jun 27, 2025, 3:30 PM KST
6.94%
Market Cap 176.69B
Revenue (ttm) 205.07B
Net Income (ttm) 33.14B
Shares Out 5.88M
EPS (ttm) 5,635.88
PE Ratio 5.33
Forward PE 5.27
Dividend 900.00 (3.00%)
Ex-Dividend Date Dec 27, 2024
Volume 15,857
Average Volume 27,999
Open 30,400
Previous Close 30,450
Day's Range 29,650 - 30,400
52-Week Range 23,750 - 32,200
Beta 0.19
RSI 56.39
Earnings Date Aug 13, 2025

About Daihan Pharmaceutical

Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1945
Employees 553
Stock Exchange KOSDAQ
Ticker Symbol 023910
Full Company Profile

Financial Performance

In 2024, Daihan Pharmaceutical's revenue was 204.19 billion, an increase of 4.23% compared to the previous year's 195.91 billion. Earnings were 33.76 billion, an increase of 18.76%.

Financial Statements

News

There is no news available yet.